Cme Slides Forum

CME SLIDES FORUM

Archive

	Adipokine signaling and the kidney		Metabolic role of natriuretic peptide – is it important for renal failure?
Dr. Peter Barany Division of Renal Medicine Department of Clinical Science, Intervention, and Technology Karolonska Institutet Karolinska University Hospital Stockholm, Sweden		Dr. Max Lafontan UMR 1048 Institut des Maladies Métaboliques et Cardiovasculaires Toulouse, France

	Vasopressin as a risk factor for CKD
Prof. Ron T. Gansevoort Department of Nephrology University Medical Center Groningen University of Groningen Groningen, The Netherlands

	Salt in space		Angiogenesis in peritoneal dialysis
Dr. Jens Titze Medizinischeklink IV Universitaet Erlangen-Nürnberg Erlangen, Germany		Prof. Robert H.J. Beelen Department of Molecular Cell Biology and Immunology VU University Medical Center Amsterdam, The Netherlands

	Therapeutic inhibition of angiogenesis and the kidney
Prof. Christian Hugo Universitaetsklinikum Carl Gustav Carus Medizinische Klinikum III Dresden, Germany

	Living donor exchange programme		Genetics of renal allograft rejection
Prof. Willem Weimar Department of Kidney Transplantation Erasmus Medical Center Rotterdam, The Netherlands		Dr. Marc Abramowicz Genetics Department Hôpital Erasme - ULB Brussels, Belgium

	Extended criteria donors: where is the limit?
Dr. Wolfgang Arns Cologne General Hospital Merheim Medical Center Cologne, Germany

	Side effects of medical treatment of cancer		Phosphate and biphosphonate
Dr. Sylvie Rottey Department of Oncology Ghent University Hospital Ghent, Belgium		Dr. Simon Desmeules Department of Medicine Centre Hospitalier Universitaire de Québec-Hôtel-Dieu de Québec Québec City, Canada

	Contrast
Dr. Giancarlo Marenzi Department of Cardiovascular Sciences University of Milan Milan, Italy

	Extended (daily) dialysis		Dialysis choice in disaster circumstances
Prof. Jan T. Kielstein Dept. of Nephrology and Hypertension Medical School Hannover Hannover, Germany		Prof. Mehmet Sukru Sever Dept. of Internal Nephrology Istanbul School of Medicine Istanbul, Turkey

	Intermittent or continuous: anything new?
Prof. Wim Van Biesen Renal Division University Hospital Ghent Ghent, Belgium

	Microvesicle - mediated transfer of genetic information		TLR2 and activation of human resident renal stem/progenitor cells
Prof. Giovanni Camussi Department of Internal Medicine, Centre for Molecular Biotechnology and Centre for Research in Experimental Medicine (CeRMS) Torino, Italy		Dr. Fabio Sallustio Nephrology, Dialysis and Transplantation Unit Department of Emergency and Organ Transplantation University of Bari Bari, Italy

	Parietal cells: an emerging cell type and its role in FSSG
Dr. Marcus J. Moeller Department of Nephrology and Clinical Immunology University Hospital of RWTH Aachen University Aachen, Germany

Renal function, albuminuria and CKD: insights from genome-wide association studies

Epigenetics and kidney disease

Dr. Carsten Böger
Dept. Internal Medicine 2
University Medical Center
Regensburg, Germany

Dr. Louise Nordfors
Department of Molecular Medicine and Surgery
Neurogenetics Unit
Karolinska University Hospital
Stockholm, Sweden

	AKI		Glomerulonephritis
Prof. Miet Schetz Department of Intensive Care Medicine University of Leuven Leuven, Belgium		Prof J. Feehally Dept of Nephrology Leicester General Hospital Leicester, United Kingdom

	Progression of kidney failure		Haemodialysis
Prof. Vladimir Tesar Department of Nephrology First Faculty of Medicine Charles University Prague, Czech Republic		Prof. Silvie Dusilova Sulkova Department of Nephrology Institute for Clinical and Experimental Medicine Prague, Chzech Republic

	Peritoneal Dialysis
Dr. Olof Heimbürger Div. Renal Medicine, K56 Karolinska University Hospital Stockholm, Sweden


	Encapsulating peritoneal sclerosis		Calciphylaxis
Dr Angela M. Summers Renal Research Labs Manchester Royal Infirmary Manchester, United Kingdom		Dr V.M. Brandenburg Department of Nephrology & Clinical Immunology University Hospital Aachen Aachen, Germany

	Ideal time for starting renal replacement therapy		Which role for incremental peritoneal dialysis
Dr Friedo Dekker Clinical Epidemiology Leiden University Medical Center Leiden, The Netherlands		Dr Giusto Viglino Nephrology and Dialysis Hospital San Lazzaro Alba, Italy

	Unplanned start on assisted peritoneal dialysis
Dr Johan V. Povlsen Department of Renal Medicine C Aarhus University Hospital Skejby Aarhus, Denmark

RAAS blockade in native and grafted kidneys

Is there a role for new anti-b cells and anti-complement agents in kidney transplant patients

Prof Przemyslaw Rutkowski
Chair and Department of Nephrology
Transplantation and Internal Diseases
Medical University Gdansk
Gdansk, Poland

Prof Lionel Rostaing
Organ Transplant Unit
Nephrology and Dialysis Unit
CHU Toulouse-Rangueil
Toulouse, France

	Hemoglobin variability in non-dialysis CKD patients		Anemia management in patients with CKD: European Best Practice Recommendations
Prof A.L.M. De Francisco Universidad de Cantabria Chief Clinic of the Nephrology Department Valdecilla Universitary Hospital Santander, Spain		Prof. F. Locatelli Dipartimento Nefro-Urologico Ospedale "A. Manzoni" Lecco, Italy

	Modifying iron balance in CKD patients, is BMP signalling a reasonable target?
Dr. Donald Reddan University College Galway Merlin Park Hospital Galway, Ireland

Current therapies in membranous nephropathy

Dr José Ballarin
Fundació Puigvert
Barcelona, Spain

Organization and activities of the Immunonephrology Working Group

Proposals of new collaborative studies on rare diseases and recurrent glomerular diseases after transplantation

Prof M.R. Daha
Dept of Nephrology
Leiden University Medical Center
Leiden, The Netherlands

Prof Jürgen Floege
Division of Nephrology
RWTH University of Aachen
Aachen, Germany

	Nutritional initiatives to decrease cardiovascular risk in CKD		Limitations of statin treatment in the prevention of cardiovascular events in dialysis patients
Dr Michal Chmielewski Department of Nephrology, Transplantology and Internal Medicine Medical University Gdansk, Poland		Prof Bengt Fellström Department of Nephrology University Hospital, Uppsala, Sweden

	Atherosclerosis and vascular calcification and CKD - insights from animal models
Prof Ziad Massy Nephrology and Clinical Pharmacology Departments University Hospital of Amiens Amiens, France

	Is cardiorenal syndrome a new entity? Pro		Is cardiorenal syndrome a new entity? Con
Dr. Claudio Ronco Divisione di Nefrologia Ospedale San Bortolo Vicenza, Italy		Prof. Walter H. Hörl Division of Nephrology and Dialysis Department of Medicine III Medical University of Vienna Vienna, Austria

	Impact of various manifestations of renal dysfunction on heart failure
Prof. Cerjan Navis Chair of Experimental Nephrology and Renal Pharmacology Department of Medicine University Medical Center Groningen, The Netherlands

	The culprit of osteoporosis in CKD		Calcium metabolism changes after transplantation
Prof Marie-Helene Lafage-Proust Université de Lyon Institut National de la Santé et de la Recherche Medical (INSERM) 890, CHU Saint-Etienne, France		Dr. Pieter Evenepoel Div. Nephrology, Dialysis and Transplantation University Hospital Gasthuisberg Leuven, Belgium

	Adynamic bone disease: from bone to vessels
Dr. Jordi Bover Fundació Puigvert Barcelona, Spain

	Potential repairing process of renal progenitor cells in tubular damage		Aldosterone-receptor antagonism in hypertension: where do we stand
Prof. Francesco Paolo Schena Head of the Nephrology, Dyalisis and Transplant Unit of Bari University Bari, Italy		Dr. Anton H. van den Meiracker Division of Pharmacology Vascular and Metabolic Diseases Department of Internal Medicine Erasmus Medical Center Rotterdam, The Netherlands

	Arterial stiffness in renal transplant recipients
Dr. Francis Verbeke Renal Unit University Hospital Gent Gent, Belgium

	Polyomavirus infection in renal transplantation		Immunosuppression
Dr. Cristina Costa Virology Unit Department of Public Health and Microbiology University of Turin Turin, Italy		Prof. Uwe Heemann II. Medizinische Klinik und Poliklinik der Technischen Universitaet Muenchen Klinikum rechts der Isar Abteilung fuer Nephrologie Munich, Germany

	What should we be doing about renal preservation?		Sustained improvement of graft survival: is it feasible?
Dr. Nizam Mamode Guys and Great Ormond Street Hospitals MRC Centre for Transplantation and NIHR Biomedical Research Centre London, United Kingdom		Prof. J.M. Campistol Nephrology and Renal Transplant Department Hospital Clinic Universtity of Barcelona Barcelona, Spain

	Current impact of HLA compatibility and immunosuppression on graft survival
Prof. G. Opelz Institute of Immunology University of Heidelberg Heidelberg, Germany

	The impact of physical fitness on morbidity and quality of life in patients with CKD		The effects of exercise training on muscle with special reference to patients with CKD
Dr. Kirsten Anding-Rost KfH-Nierenzentrum Bischofswerda, Germany		Prof. Tom Mercer School of Health Sciences Faculty of Health and Social Science Queen Margaret University College Edinburgh, United Kingdom

	Physical fitness - an integral part of comprehensive care of CKD patients
Prof. Rolfdieter Krause KfH - Dialysezentrum Moabit Berlin, Germany

	Arrhythmias in dialysis patients		Biocompatibility and genomics in dialysis
Prof. Walter H. Hörl Division of Nephrology and Dialysis Department of Medicine III Medical University of Vienna Vienna, Austria		Dr. Rainer Oberbauer Department of Nephrology KH Elisabethinen Linz and Medical University of Vienna and Austrian Dialysis and Transplant Registry Vienna, Austria

	Impact of a haemodialysis session for myocardial perfusion
Dr. Christopher W. McIntyre Department of Renal Medicine Royal Derby Hospital Derby, United Kingdom

C4D deposition in IGA Nephropathy

Renal biopsy in IGA Nephropathy: the Oxford classification and beyond

Dr Mario Espinosa
Nephrology Department
University Hospital Reina Sofia
Cordoba, Spain

Dr Ian Roberts
Department of Cellular Pathology
John Radcliffe Hospital
Oxford, United Kingdom

	Pathophysiology of the peritoneal interstitium and mesothelial cells in ultrafiltration failure (UFF)		Dynamic interactions between peritoneum and abdominal adipocytes: the effect of peritoneal dialysis solutions
Prof Bengt Rippe Nephrology Department University Hospital Lund Lund, Sweden		Dr Daniel Teta Division de Nephrologie CHUV Lausanne Lausanne, Switzerland

	Current outcomes in peritoneal dialysis		Financial aspects in peritoneal dialysis
Prof Giovanni Cancarini U.O. Nefrologia A.O. Spedali Civili di Brescia Brescia, Italy		Dr Jacques Chanliau Association lorraine de traitement de l'insuffisance rénale (ALTIR) Vandœuvre, France

	Multicenter experience with low-sodium peritoneal dialysis solutions
Prof Simon J Davies Department of Nephrology North Staffs Royal Infirmary Stoke-on-Trent, United Kingdom

	Klotho, FG23 and Vitamin d: a bone-kidney story and much more		Beyond CA/P/PTH: clinical evidence of a link between the adipose tissue and bone disease in ESRD
Prof Gérard Friedlander Département de Physiologie et Radio-Isotopes Hôpital Européen Georges Pompidou Paris, France		Prof Andrzej. Wiecek Department of Nephrology, Endocrinology and Metabolic Diseases Silesian University School of Medicine Katowice, Poland

	Vascular calcifications as a risk factor for cardiovascular mortality		Vascular calcification: can we control progression and regression?
Dr Leon Schurgers Department of Biochemistry University Maastricht Maastricht, The Netherlands		Prof J. Cannata-Andia Servicio de Metabolismo Oseo y Mineral Instituto “Reina Sofía” de Investigación. REDinREN – ISCIII. Hospital Universitario Central de Asturias. Universidad de Oviedo Oviedo, Spain


	Optimization of immunosuppressants dosing in renal transplantation		Genome wide analysis and transplantation: what is it and what could it bring us?
Prof Yannick Le Meur Service de Néphrologie CHU la Cavale Blanche Brest, France		Prof Dirk R.J. Kuypers Department of Nephrology and Renal Transplantation University of Leuven Leuven, Belgium

	Population pharmacokinetics in renal transplantation
Prof Oriol Manuel Transplantation Center and Service of Infectious Diseases University Hospital of Lausanne Lausanne, Switzerland

	New insights from clinical studies		Metabolism
Prof Z. Massy Nephrology and Clinical Pharmacology Departments, University Hospital of Amiens, Amiens, France		Prof R. Vanholder Professor of Medicine at the University of Ghent, Belgium, Associate Head of the Nephrology Division of the Ghent University Hospital Ghent, Belgium

	Biomarkers: when is it justified to incorporate a new biomarker into clinical practice?
Prof C. Zoccali Unità di Nefrologia, Dialisi, Trapianto e Ipertensione OO.RR and CNR Istituto di Biomedicina Laboratorio di Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione Reggio Calabria, Italy

Update on the treatment of idiopathic FSGS

Cardiotrophin-like cytokine-1, potential FSGS permeability factor

Prof. Alain Meyrier
Department of Nephrology
University Paris-Descartes
Hôpital Georges Pompidou and Broussais
Paris, France

Prof. Virginia Savin
Kidney Institute
University of Kansas Medical Center
Kansas City, KS, USA

	Inflammatory mechanisms in AKI		TWEAK/FN14 in acute kidney injury
Prof. Marc De Broe Department of Nephrology University of Antwerp Antwerpen, Belgium		Dr. Alberto Ortiz Dpto de Nefrología Experimental y Patología Vascular IIS-Fundación Jiménez Díaz Madrid, Spain

	Hypoxia and renal injury
Dr. Michael S. Wiesener Department of Nephrology and Hypertension University of Erlangen-Nuremberg Erlangen, Germany

	Intrauterine growth and the risk of CKD in adulthood		Fructose, the metabolic syndrome and renal disease
Prof Stein Hallan Department of Medicine Division of Nephrology St. Olav University Hospital Trondheim, Norway		Prof Richard J. Johnson Temple Hoyne Buell and NKF of Colorado Endowed Division of Renal Diseases and Hypertension University of Colorado Denver, CO, USA

	Obesity and metabolic syndrome: an emerging threat to renal function
Prof Eberhard Ritz Dept. Internal Medicine Division Nephrology Heidelberg, Germany

	Recent trends in the epidemiology of renal replacement therapy: good news for the nephrologist?		The EVEREST study: exploring the worldwide variation in RRT incidence
Dr Vianda Stel ERA-EDTA Registry - Dept. of Medical Informatics Academic Medical Center Amsterdam, The Netherlands		Dr Fergus Caskey UK Renal Registry Southmead Hospital Bristol, United Kingdom

	The launch of new ERA-EDTA codes for primary renal diagnosis
Dr Charles Tomson Department of Nephrology Southmead Hospital Bristol, United Kingdom

	ACE2 and chronic kidney disease		Modification of mineralocorticoid receptor function in proteinuric kidney disease
Dr. Maria Josè Soler Romeo Nephrology Department Hospital del Mar Barcelona Barcelona, Spain		Dr. Toshiro Fujita Department of Nephrology and Endocrinology University of Tokyo Graduate School of Medicine Tokyo, Japan

	ACE2: a new target for cardiovascular disease therapeutics		Clinical value of aldosterone antagonism
Prof. Mohan Raizada Department of Physiology and Functional Genomics University of Florida, College of Medicine Gainesville, FL, USA		Prof. Michel Burnier Division of Nephrology and Hypertension Consultation Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland

	Role of aldosterone in oxidative stress and renal injury
Prof. Akira Nishiyama Department of Pharmacology Kagawa University Medical School Kagawa, Japan

	Peritoneal dialysis and hemodialyis therapy in elderly patients		Peritoneal membrane evaluation in clinical practice
Dr. Peter Blake London Health Sciences Centre Victoria Hospital London, Ontario, Canada		Prof. R. Krediet Chief Division of Nephrology Academic Medical Centre Amsterdam, The Netherlands

	Maintaining the peritoneal membrane - from pathophysiology to clinic		Mesothelial cell biology and its alterations in PD
Prof Nicholas Topley Institute of Nephrology School of Medicine, Cardiff University Cardiff, United Kingdom		Prof Janusz Witowski Department of Pathophysiology Poznań University of Medical Sciences Poznań, Poland

	Relative roles of promoters and inhibitors of vascular calcification in CRF		Imaging vascular calcifications: precision, x-ray exposure, cost and predictive value
Prof Ralf Westenfeld Department of Nephrology Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Hospital Aachen, Germany		Prof Paolo Raggi Division of Cardiology and Department of Medicine Emory University Atlanta, GA, USA

	Ionized, corrected, or total serum calcium in CKD? An unresolved clinical issue		ROD: definition, classification, diagnosis, indications of bone biopsy
Prof Pascal Houillier Département de Physiologie et radio-isotopes AP-HP, Hôpital Européen Georges Pompidou Paris, France		Prof Marie-Helene Lafage-Proust Université de Lyon Institut National de la Santé et de la Recherche Medical (INSERM) 890, CHU Saint-Etienne, France

	Diagnosis of ROD by circulating surrogate markers compared with bone histology
Prof Anibal Ferreira Department of Nephrology Hospital Curry Cabral and Faculdade de Ciências Médicas Universidade Nova de Lisboa Lisbon, Portugal

	Determinants of long term progression - results from the MMKD study		Magic bullet or multiple interventions to reverse kidney disease progression?
Prof F. Kronenberg Division of Genetic Epidemiology Department of Medical Genetics Molecular and Clinical Pharmacology Innsbruck Medical University Innsbruck, Austria		Prof G. Remuzzi Mario Negri Institute for Pharmacological Researches Negri Bergamo Laboratories Bergamo, Italy

	Tubular toxicity of proteinuria		Anti-proteinuric doses of RAS inhibitors: efficacy for renoprotection
Prof N.J. Brunskill Department of Infection, Immunity and Inflammation University of Leicester Leicester, United Kingdom		Prof F.F. Hou Division of Nephrology Nanfang Hospital Southern Medical University Guangzhou, P.R.China

	The complexity of the filtration barrier
Prof D. Kerjaschki Department of Pathology Medical University of Vienna Allgemeines Krankenhaus Vienna, Austria

	Hepcidin - bringing new knowledge of molecular mechanisms into the clinic		How well controlled is hyperparathyroidism in today's practice? The magnitude of the problem
Dr Dorine W. Swinkels Department of Clinical Chemistry Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands		Prof J. Cannata-Andia Servicio de Metabolismo Oseo y Mineral Instituto “Reina Sofía” de Investigación. REDinREN – ISCIII. Hospital Universitario Central de Asturias. Universidad de Oviedo Oviedo, Spain

	Mechanisms underlying parathyroid hyperplasia		Bone as an endocrine organ: FGF 23 and the parathyroid
Dr. Adriana S. Dusso Renal Division Washington University School of Medicine St. Louis, MO, USA		Prof Justin Silver Department of Nephrology and Hypertension Hadassah University Hospital Ein-Karem, Jerusalem

	Intestinal signals regulate renal solute excretion		Cardiotonic steroids (endogenous digitalis)
Dr R. Kumar Division of Nephrology and Hypertension Department of Medicine, Mayo Clinic Rochester, MN, USA		Dr Alexei Y. Bagrov Laboratory of Cardiovascular Science National Institute on Aging, NIH Baltimore, MD, USA

	Non-osmotic sodium storage		Management of the ckd patient: salt restriction, diuretics or both?
Dr Jens Titze Medizinische Klinik 4 Nikolaus-Fiebiger Center for Molecular Medicine Erlangen, Germany		Prof B. Rodriguez-Iturbe Hospital Universitario de Maracaibo Centro de Investigaciones Biomedicas Maracaibo, Venezuela

	The role of rituximab in vasculitis therapy		New experimental data on the pathogenesis of ANCA associated vasculitis
Dr David Jayne University of Cambridge School of Clinical Medicine Addenbrooke's Hospital Cambridge, United Kingdom		Dr Renate Kain Institute of Clinical Pathology Medical University of Vienna Vienna, Austria

	B cells and the kidney		Lupus nephritis: clinical trials and novel therapies
Dr Betty Diamond The Feinstein Institute for Medical Research Center of Autoimmune and Musculoskeletal Diseases Manhasset, NY, USA		Dr Charles Pusey Faculty of Medicine Imperial College London, United Kingdom

	Diagnostic criteria for protein-energy wasting		Therapeutic interventions for protein-energy wasting in chronic kidney diseases
Dr Denis Fouque Department of Nephrology Hospital Edouard Herriot University Lyon 1 Lyon, France		Prof. William E. Mitch Department of Nephrology Hospital Edouard Herriot University Lyon 1 Lyon, France

	Achieving blood pressure control and the risk of intradialytic hypotension
Dr Andrew Davenport University College London Center for Nephrology Royal Free Hospital London, United Kingdom

	Evidence-based therapy for idiopathic membranous nephropathy-2009		Immune mechanisms of interstitial inflammation in membranous nephropathy
Prof. Richard Glassock The David Geffen School of Medicine at UCLA Los Angeles, CA, USA		Prof. David Harris Department of Renal Medicine and Transplantation The University of Sydney at Westmead Hospital Westmead, Australia

	Natural history and prognostic factors		Complement components in membranous nephropathy
Prof C. Ponticelli IRCCS Istituto Auxologico Italiano Milan, Italy		Prof. Richard J. Quigg Section of Nephrology University of Chicago Chicago, IL, USA

	Interstitial and infection related nephritis
Prof. Jan A. Bruijn Department of Pathology Leiden University Hospital Leiden, The Netherlands

	Blood pressure effects of VEGF antagonism		VEGF antagonism as a cause of preeclampsia
Dr Michel Azizi Clinical Investigation Center, Inserm George Pompidou European Hospita, APHP Paris, France		Dr Sharon E. Maynard School of Medicine George Washington University Washington, D.C., USA

	ADMA, blood pressure and renal function: from saltsensitivity to heart failure		ADMA, endothelial dysfunction and the risk of cardiovascular and renal diseases
Prof D. Fliser Renal and Hypertensive Disease University Medical Centre Homburg/Saar, Germany		Prof C. Zoccali Unità di Nefrologia, Dialisi, Trapianto e Ipertensione OO.RR and CNR Istituto di Biomedicina Laboratorio di Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione Reggio Calabria, Italy

	Classical and non classical nitric oxide signaling in vascular disease
Dr S. Lamas Centro Nacional de Investigaciones Cardiovasculares Consejo Superior de Investigaciones Científicas Madrid, Spain

	New membranes		Use of the serum free light chain assay
Dr Colin A. Hutchison Department of Nephrology University Hospital Birmingham Birmingham, United Kingdom		Dr Helen J. Lachmann UK National Amyloidosis Centre University College London Medical School London, United Kingdom

	The use of plasmapheresis		Indications to plasma infusion and plasma exchange
Dr François Madore University of Montréal Hôpital du Sacré-Coeur de Montréal Montréal, Quebec, Canada		Prof. C. Loirat Service de Nephrologie Pediatrique Hopital Robert Debre Paris, France

	Natural course and perspectives for medical therapy in AA amyloidosi
Dr. Martha Skinner Amyloid Treatment and Research Program Boston University School of Medicine Boston, USA

	The renal epithelial sodium channel and hypertension		WNK kinases and hypertension
Prof David G. Warnock Department of Nephrology University of Alabama at Birmingham Birmingham, AL, USA		Prof Xavier Jeunemaitre INSERM U772 Collège de France Paris, France

	Finding the genes of hypertension: lessons from the hypergenes project		Lessons from autosomal dominant hypertension and brachydactylie
Prof Daniele Cusi Division of Nephrology and Dialysis San Carlo Borromeo Hospital Milano, Italy		Prof Friedrich C. Luft Charité Campus Buch Experimental and Clinical Research Center (ECRC) Berlin, Germany

	ASTRAL study: results and implications		Results of the STAR study
Dr Philip A. Kalra Department of Renal Medicine Salford Royal Hospital Salford, United Kingdom		Dr. Jaap J. Beutler Jeroen Bosch Hospital, Den Bosch University Medical Center Utrecht, The Netherlands

	Long-term kidney graft survival - are we doing any better?		Early EMT in renal grafts is correlated with outcome
Prof Gerhard Opelz Department of Transplantation Immunology University of Heidelber Heidelberg, Germany		Prof Eric Rondeau Service de Nephrologie A Hopital Tenon Paris, France

	The pro and con of protocol biopsies		Renin-angiotensin system blockade in kidney transplantation
Prof Hermann Haller Division of Nephrology Department of Medicine, School of Medicine University of Hannover Hannover, Germany		Prof Jack F.M. Wetzels Department of Nephrology Radboud University Nijmegen Nijmegen, The Netherlands

	Progression of FABRY nephropathy		Treatment choices for FABRY nephropathy
Dr R. Schiffmann Institute of Metabolic Disease Baylor Research Institute Dallas, TX, USA		Prof C.Wanner Bayerische-Julius-Maximilans University Department of Medicine, Division of Nephrology Würzburg, Germany

	Transplant, dialysis and CVD in FABRY disease
Dr R. Mignani Renal Unit Infermi Hospital Rimini, Italy

	Evaluation of physical activity in CKD: applicability of simple too		Asessment of functional capacity in CKD patients
Dr L. Cuppari Division of Nephrology Federal University of Sao Paulo Sao Paulo, Brazil		Dr P. Koufaki Department of Sports and Exercise Science Stirling University Stirling, United Kingdom

	Growth hormone improves nutrition, quality of life and cardiovascular risk factors in ESRD
Dr B. Feldt-Rasmussen Department of Nerphrology Rigshospitalet Copenhagen, Denmark

	Intestinal phosphate absorption: cross-talk with the kidney		Molecular control of renal phosphate reabsorption
Dr R. Kumar Division of Nephrology and Hypertension Department of Medicine, Mayo Clinic Rochester, MN, USA		Prof. Heini Murer Center for Integrative Human Physiology University of Zurich Zurich, Switzerland

	Phosphate, pyrophosphate and bisphosphonates in uremic vascular calcification		FGF23 and klotho in patients with CKD
Prof. W. Charles O'Neill Renal Division Emory University Atlanta, GA, USA		Dr. M. Fukagawa Division Nephrology and Kidney Center Kobe University School of Medicine Kobe, Japan

The interplay between hyperglycemia and vascular hemodynamics

Advanced glycation, hypoxia and oxidative stress

Dr. Luigi Gnudi
Unit for Metabolic Medicine, Cardiovascular Division
King's College London
London, United Kingdom

Prof. T. Miyata
Center for Translational and Advanced Research
Tohoku University Graduate School of Medicine
Sendai, Japan

An integrated proteomic approach to plasma and urinary proteins in nephrotic syndrome

FSGS - primary vs. Secondary forms, congenital mutations vs non-genetic types

Dr. G.M. Ghiggeri
Department of Nephrology
Dialysis and Transplantation
Giannina Gaslini Children Hospital
Genova, Italy

Dr. M.C. Gubler
Inserm U574, Ventre de reference MARHEA
Hopital Necker - Enfant Malades
Université Paris Descartes
Paris, France

Tropical infections and glomerulonephritis

Dr. M.R. Francis
Pathology Department
Kasr El Aini Faculty of Medicine
Cairo, Egypt

	Fairness (and its limits) in humans		Lymphangiogenesis in development and disease
Prof. E. Fehr Institute for Empirical Research in Economics University of Zurich Zurich, Switzerland		Prof. K. Alitalo Molecular/Cancer Biology Laboratory Biomedicum Helsinki and Department of Pathology Haartman Institute, University of Helsinki Helsinki, Finland

	Remote ischemic preconditioning
Dr. D.M. Hausenloy The Hatter Cardiovascular Institute University College London London, United Kingdom